Abcam Plc (LON:ABC) had its price objective raised by analysts at Numis Securities Ltd from GBX 1,116 ($14.41) to GBX 1,200 ($15.50) in a note issued to investors on Tuesday. The brokerage presently has an “add” rating on the stock. Numis Securities Ltd’s price target indicates a potential upside of 13.64% from the stock’s current price.

Other equities research analysts also recently issued reports about the company. Berenberg Bank began coverage on Abcam Plc in a report on Tuesday, June 27th. They issued a “buy” rating and a GBX 1,100 ($14.21) price objective for the company. Peel Hunt reissued a “hold” rating and issued a GBX 750 ($9.69) target price on shares of Abcam Plc in a research report on Monday. J P Morgan Chase & Co reissued a “neutral” rating and issued a GBX 864 ($11.16) target price on shares of Abcam Plc in a research report on Tuesday. Finally, Panmure Gordon reissued a “sell” rating on shares of Abcam Plc in a research report on Monday. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of GBX 914 ($11.80).

Abcam Plc (ABC) opened at 1079.00 on Tuesday. Abcam Plc has a one year low of GBX 725.50 and a one year high of GBX 1,090.00. The company has a 50 day moving average of GBX 1,049.86 and a 200-day moving average of GBX 950.84. The stock’s market capitalization is GBX 2.18 billion.

ILLEGAL ACTIVITY WARNING: “Numis Securities Ltd Boosts Abcam Plc (ABC) Price Target to GBX 1,200” was posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at

Abcam Plc Company Profile

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam Plc (LON:ABC)

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with's FREE daily email newsletter.